Skip to main content

Differential Evolution Analysis of Clinical Characteristics of Severe Viral Pneumonia in Children

Buy Article:

$107.14 + tax (Refund Policy)

The effects of acetylcysteine on the proliferation of lung fibroblasts in normal and severe viral pneumonia children were compared. Children with severe viral pneumonia and normal lung fibroblasts were isolated and cultured, and the effects of lung fibroblast proliferation and acetylcysteine on normal lung fibroblasts and children with severe viral pneumonia were observed, the effect of acetylcysteine dose gradient on the proliferation of alveolar epithelial cell A549 was compared. It can inhibit the proliferation of lung fibroblasts in both normal and severe viral pneumonia children. Then, the improved two-stage differential evolution algorithm was used to optimize the clinical characteristics of severe viral pneumonia in children by aerosol inhalation of acetylcysteine, the results showed that the inhibitory effect of acetylcysteine was dose-dependent in normal lung fibroblasts, and cell proliferation was basically stopped when the concentration reached 40 mM. However, the inhibitory effect of acetylcysteine on the proliferation of pulmonary fibroblasts in children with severe viral pneumonia did not increase with the increase of concentration, and the cell proliferation continued at 40 mM. Acetylcysteine can inhibit the proliferation of lung fibroblasts, and the inhibitory effect has cell specificity in a certain concentration range.

Keywords: ACETYLCYSTEINE; COLLAGEN SYNTHESIS; DIFFERENTIAL EVOLUTION; FIBROBLASTS; PROLIFERATION; VIRAL PNEUMONIA

Document Type: Research Article

Publication date: 01 January 2020

More about this publication?
  • Journal of Medical Imaging and Health Informatics (JMIHI) is a medium to disseminate novel experimental and theoretical research results in the field of biomedicine, biology, clinical, rehabilitation engineering, medical image processing, bio-computing, D2H2, and other health related areas.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content